(Q38145895)

29 August 2017

1 reference

title

Perindopril. A review of its pharmacokinetics and clinical pharmacology (English)

1 reference

29 August 2017

1 reference

1 reference

Macfadyen RJ

1

1 reference

29 August 2017

Lees KR

series ordinal

2

1 reference

29 August 2017

Reid JL

series ordinal

3

1 reference

29 August 2017

publication date

1 January 1990

1 reference

29 August 2017

1 reference

29 August 2017

volume

39 Suppl 1

1 reference

29 August 2017

page(s)

49-63

1 reference

Heart rate control in hypertensive patients treated by captopril

29 August 2017

cites work

1 reference

12 December 2020

The pharmacokinetics of enalapril in hospitalized patients with congestive heart failure

1 reference

12 December 2020

Discrepancy between first-dose converting enzyme inhibition at rest and subsequent inhibition during exercise in chronic heart failure

1 reference

12 December 2020

Effects of perindopril on renal haemodynamics and natriuresis in essential hypertension

1 reference

12 December 2020

Myocardial effect of converting enzyme inhibition in hypertensive and normotensive rats

1 reference

12 December 2020

Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

12 December 2020

Inhibition of angiotensin converting enzyme: mechanism and substrate dependence

1 reference

12 December 2020

Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects

1 reference

12 December 2020

Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction

1 reference

12 December 2020

Perindopril: first-line treatment for hypertension

1 reference

12 December 2020

Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive rats

1 reference

12 December 2020

Indirect assessment of tissue angiotensin II converting enzyme inhibition in vivo in man

1 reference

12 December 2020

Effects of intravenous S-9780, an angiotensin-converting enzyme inhibitor, in normotensive subjects

1 reference

12 December 2020

Perindopril, converting enzyme blockade, and peripheral arterial hemodynamics in the healthy volunteer.

1 reference

12 December 2020

Antihypertensive action of the converting enzyme inhibitor perindopril (S9490-3) in spontaneously hypertensive rats: comparison with enalapril (MK421) and ramipril (Hoe498).

1 reference

12 December 2020

The NH2-and COOH-terminal sequences of the angiotensin-converting enzyme isozymes from rabbit lung and testis

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors: measurement of relative inhibitory potency and serum drug levels by radioinhibitor binding displacement assay

1 reference

12 December 2020

Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical res

1 reference

12 December 2020

Pharmacokinetics of the converting enzyme inhibitor cilazapril in normal volunteers and the relationship to enzyme inhibition: development of a mathematical model

1 reference

12 December 2020

Effects of perindopril on tissue angiotensin-converting enzyme activity demonstrated by quantitative in vitro autoradiography

1 reference

12 December 2020

Age and the pharmacokinetics and pharmacodynamics of chronic enalapril treatment

1 reference

12 December 2020

The physiological disposition and metabolism of enalapril maleate in laboratory animals

1 reference

12 December 2020

Regulation of regional vascular tone: the role of angiotensin conversion in human forearm resistance vessels.

1 reference

12 December 2020

Effects of perindopril on ambulatory intra-arterial blood pressure, cardiovascular reflexes and forearm blood flow in essential hypertension

1 reference

12 December 2020

Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats

1 reference

12 December 2020

The pharmacokinetics and pharmacodynamics of perindopril in patients with hepatic cirrhosis

1 reference

12 December 2020

Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group

1 reference

12 December 2020

Enalapril. An update of its pharmacological properties and therapeutic use in congestive heart failure

1 reference

12 December 2020

Myocardial and vascular effects of perindopril, a new converting enzyme inhibitor, during hypertension development in spontaneously hypertensive rats

1 reference

12 December 2020

Inhibition of angiotensin converting enzyme (ACE) in plasma and tissues: studies ex vivo after administration of ACE inhibitors

1 reference

12 December 2020

Effects of perindopril on angiotensin converting enzyme in tissues of the rat.

1 reference

12 December 2020

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

12 December 2020

Tissue converting enzyme and cardiovascular actions of converting enzyme inhibitors

1 reference

12 December 2020

Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril

1 reference

12 December 2020

Therapeutic options in the management of chronic heart failure. Is there a drug of first choice?

1 reference

12 December 2020

The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

12 December 2020

Differential angiotensin-converting enzyme inhibition in brain after oral administration of perindopril demonstrated by quantitative in vitro autoradiography

1 reference

12 December 2020

Kinetic and inhibitory characteristics of serum angiotensin-converting enzyme from nine mammalian species

1 reference

12 December 2020

Haemodynamic Responses to Specific Renin-Angiotensin Inhibitors in Hypertension and Congestive Heart Failure A Review

1 reference

12 December 2020

Angiotensin converting enzyme inhibitors and ischaemic heart disease

1 reference

12 December 2020

Age and the pharmacokinetics of angiotensin converting enzyme inhibitors enalapril and enalaprilat

1 reference

12 December 2020

Effect of Captopril on Renal Vascular Tone in Patients with Essential Hypertension

1 reference

12 December 2020

Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril

1 reference

12 December 2020

Skeletal muscle blood flow, metabolism and morphology in chronic congestive heart failure and effects of short- and long-term angiotensin-converting enzyme inhibition.

1 reference

12 December 2020

Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

12 December 2020

Antihypertensive effects of S9490-3, a new converting enzyme inhibitor, in the conscious spontaneously hypertensive rat

1 reference

12 December 2020

The present molecules of converting enzyme inhibitors

1 reference

12 December 2020

Captopril versus perindopril: a double blind study in essential hypertension

1 reference

12 December 2020

Angiotensin and the renal circulation in hypertension

1 reference

12 December 2020

Biochemical and immunological studies of angiotensin converting enzymes from human, bovine, dog, hog, rabbit, rat and sheep kidneys

1 reference

12 December 2020

The renin-angiotensin-aldosterone system and the clinical course of acute myocardial infarction

1 reference

12 December 2020

Need for plasma angiotensin measurements to investigate converting-enzyme inhibition in humans

1 reference

12 December 2020

Converting enzyme inhibitors (captopril, enalapril, perindopril) prevent early-post infarction ventricular fibrillation in the anaesthetized rat.

1 reference

12 December 2020

Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria

1 reference

12 December 2020

Captopril in heart failure. A double blind controlled trial

1 reference

12 December 2020

Vascular Angiotensin-Converting Enzyme Activity in Man and other Species

1 reference

12 December 2020

Effects of antihypertensive treatment in one-clip, two kidney hypertension in rats

1 reference

12 December 2020

Localization of angiotensin converting enzyme (kininase II). II. Immunocytochemistry and immunofluorescence

1 reference

12 December 2020

Intravenous captopril treatment in patients with severe cardiac failure

1 reference

12 December 2020

Evaluation of the dose-effect relationship of a new ace inhibitor (perindopril) by an automatic blood pressure recorder

1 reference

12 December 2020

Acute and chronic effects of the converting enzyme inhibitors enalapril and lisinopril on reflex control of heart rate in normotensive man.

1 reference

12 December 2020

The haemodynamic and humoral effects of treatment for one month with the angiotensin converting enzyme inhibitor perindopril in salt replete hypertensive patients

1 reference

12 December 2020

Captopril, an angiotensin I-converting enzyme inhibitor, decreases proteinuria in hypertensive patients with renal diseases

1 reference

12 December 2020

Intravenous captopril in acute heart failure

1 reference

12 December 2020

Peripheral haemodynamic effects of perindopril compared in patients with congestive heart failure and in normal volunteers.

1 reference

12 December 2020

Neuroendocrine activation in acute myocardial infarction.

1 reference

12 December 2020

Enalapril in moderate to severe hypertension: a comparison with atenolol

1 reference

12 December 2020

Angiotensin converting enzyme inhibition decreases systolic blood pressure more than diastolic pressure as shown by ambulatory blood pressure monitoring

1 reference

12 December 2020

Converting enzyme inhibitors and brain angiotensin

1 reference

12 December 2020

Angiotensin-converting enzyme (ACE) measurement in human serum using radioinhibitor ligand binding

1 reference

12 December 2020

Single and repeated dosing of the converting enzyme inhibitor perindopril to normal subjects

1 reference

12 December 2020

Long-term hypotensive effects of an angiotensin converting enzyme inhibitor in spontaneously hypertensive rats: is there a role for vascular structure?

1 reference

12 December 2020

Comparison of the actions of the angiotensin-converting enzyme inhibitors enalapril and S-9490-3 in sodium-deplete and sodium-replete spontaneously hypertensive rats

1 reference

12 December 2020

Angiotensin converting enzyme inhibition in plasma and tissues

1 reference

12 December 2020

Biotransformation studies of di-acid angiotensin converting enzyme inhibitors

1 reference

12 December 2020

Pharmacokinetics of repeated single oral doses of enalapril maleate (mk-421) in normal volunteers

1 reference

12 December 2020

Gas chromatography-mass spectrometry of perindopril and its active free metabolite, an angiotensin convertase inhibitor: choice of derivatives and ionization modes

1 reference

12 December 2020

Influence of age on the pharmacokinetics and pharmacodynamics of perindopril

1 reference

12 December 2020

Short term effect of captopril on microalbuminuria induced by exercise in normotensive diabetics

1 reference

12 December 2020

Haemodynamic and humoral effects of oral perindopril, an angiotensin converting enzyme inhibitor, in man.

1 reference

12 December 2020

Renal effects of perindoprilat, an angiotensin-converting enzyme inhibitor, in the anesthetized dog.

1 reference

12 December 2020

Angiotensin I converting enzyme

1 reference

12 December 2020

Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

12 December 2020

Evidence of parasympathetic activity of the angiotensin converting enzyme inhibitor, captopril, in normotensive man.

1 reference

12 December 2020

Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension.

1 reference

12 December 2020

Converting-enzyme inhibitors in the treatment of hypertension

1 reference

12 December 2020

Plasma renin concentration in human hypertension . II. Renin in relation to aetiology

1 reference

12 December 2020

The effect of perindopril on blood pressure in humans on different sodium intakes

1 reference

12 December 2020

Cardiac 3,4-dihydroxyphenylethylene glycol (DHPG) and catecholamine levels during perindopril therapy of chronic left ventricular failure in rats

1 reference

12 December 2020

Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension

1 reference

12 December 2020

Relative inhibitory potency and plasma drug levels of angiotensin converting enzyme inhibitors in the rat

1 reference

12 December 2020

Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases

1 reference

12 December 2020

Renin: endocrine, paracrine, or part-paracrine control of blood pressure?

1 reference

12 December 2020

Inhibition of tissue angiotensin converting enzyme. Quantitation by autoradiography

1 reference

12 December 2020

Effect of captopril on heavy proteinuria in azotemic diabetics

1 reference

12 December 2020

Inhibition of tissue angiotensin converting enzyme by perindopril: in vivo assessment in the rat using radioinhibitor binding displacement

1 reference

12 December 2020

ACE inhibitors--the trickle becomes a flood

1 reference

12 December 2020

Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction

1 reference

12 December 2020

Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial

1 reference

12 December 2020

Effect of eight-day converting enzyme inhibition on ambulatory blood pressure recordings in normotensive volunteers

1 reference

12 December 2020

Thermal denaturation of rat pulmonary and testicular angiotensin-converting enzyme isozymes. Effects of chelators and CoCl2

1 reference

12 December 2020

Effects of angiotensin converting enzyme inhibitor, perindopril, on autonomic reflexes

1 reference

12 December 2020

Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels?

1 reference

12 December 2020

Biotransformation studies of di-acid angiotensin converting enzyme inhibitors.

1 reference

12 December 2020

The pharmacokinetics of lisinopril in hospitalized patients with congestive heart failure

1 reference

12 December 2020

Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension

1 reference

12 December 2020

10.2165/00003495-199000391-00009

Identifiers

DOI

0 references

Dimensions Publication ID

1022946169

0 references

1 reference